Is Azelastine Safe in Asthma?
Yes, intranasal azelastine is safe for stable asthmatic patients aged 12 years and older with allergic rhinitis. The FDA label explicitly states that oral azelastine has been safely administered to over 1,400 asthmatic subjects, supporting the safety of administering intranasal azelastine to allergic rhinitis patients with asthma 1.
Evidence Supporting Safety in Asthma
Direct safety data: The FDA clinical pharmacology section documents that azelastine has been tested and proven safe in a large asthma population, with no contraindications listed for asthmatic patients 1.
Mechanism of safety: Azelastine is a second-generation H1-receptor antagonist with minimal systemic absorption (approximately 40% bioavailability) when administered intranasally, limiting systemic effects that could theoretically impact asthma control 1.
Age-Specific Approval and Dosing
For patients ≥12 years: Azelastine 0.1% (Astelin) is approved at 1-2 sprays per nostril twice daily, and azelastine 0.15% (Astepro) is approved at the same dosing regimen 2.
Not approved for children <6 years: The American Academy of Otolaryngology-Head and Neck Surgery explicitly states that intranasal azelastine is not approved for children younger than 5-6 years and should not be prescribed in this age group 2, 3.
Common Side Effects to Counsel Patients About
Bitter taste is the most common adverse event, occurring in 8-9% of patients 4.
Somnolence rates are low: Recent studies show somnolence occurs in only 0.4-3% of patients, comparable to placebo rates, despite early studies reporting rates around 11% 2, 5. In one large trial, somnolence was reported by only 1.7% of patients on azelastine 0.15%, 0.6% on azelastine 0.10%, and 0.6% on placebo 4.
Epistaxis and nasal discomfort occur in approximately 4-5% of patients 6.
Clinical Efficacy in Asthmatic Patients with Allergic Rhinitis
Rapid onset of action: Azelastine works within 15-30 minutes, significantly faster than oral antihistamines 5, 4.
Effective for all nasal symptoms: Unlike oral antihistamines, intranasal azelastine effectively treats nasal congestion in addition to rhinorrhea, sneezing, and itching 2, 5.
Superior to oral antihistamines: Intranasal antihistamines show equality or superiority to oral antihistamines in well-designed randomized controlled trials, with particular benefit for nasal congestion 2.
Combination Therapy for Severe Symptoms
Add to intranasal corticosteroids if needed: For moderate-to-severe allergic rhinitis inadequately controlled by intranasal corticosteroids alone, adding azelastine provides >40% relative improvement compared to either agent alone 7, 5.
Particularly beneficial for treatment failures: This combination is especially useful for patients who have failed previous oral antihistamine therapy 5.
Important Caveats
No contraindications for asthma: The FDA label lists no contraindications related to asthma or respiratory disease 1.
Monitor for somnolence initially: Although rates are low, patients should be counseled about potential drowsiness when initiating therapy, particularly if operating machinery or driving 5.
Proper administration technique: Patients should be taught correct spray technique to minimize local side effects and maximize efficacy 2.